129 indexable Biopharma Outsourcing companies headquartered in Spain, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $85.3M across 27 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
UQUIFA Group
CDMO company manufacturing APIs and intermediates |
$42.5M | — | Acquired | Conventional Debt Mar 2025 | 28 | 1936 | ↑ Active |
| 2 |
Nanoligent
Provider of preclinical services for the development of oncology drugs |
$2.5M | — | Series A | Series A Oct 2025 | 9 | 2017 | ↑ Active |
| 3 |
Biointaxis
Biotechnology company that offers pre-clinical research and gene therapy products |
$2.4M | — | Funding Raised | Grant (prize money) Oct 2024 | 7 | 2017 | ↑ Active |
| 4 |
Leanbio
Manufacturer of biopharmaceutical product in immunotherapy |
$6.3M | — | Acquired | Angel Apr 2024 | 15 | 2014 | — |
| 5 |
ZeClinics
Provider of CRO developing zebrafish models for toxicity studies |
$5.2M | — | Funding Raised | Grant (prize money) Oct 2022 | 38 | 2013 | — |
| 6 |
Nanomol Technologies
Provider of particle design, nanoformulation technologies, and cGMP particle characterization services |
$2.3M | — | Funding Raised | Grant (prize money) Jan 2023 | — | 2010 | — |
| 7 |
Science4Tech
Provider of trial designing, launch, enrollment & feedback services for pharmaceutical industry |
$2.1M | — | Seed | Seed 2022 | 39 | 2019 | — |
| 8 |
Histocell
Provider of products and services in cell therapy for regenerative medicine |
$3.5M | — | Series A | Grant (prize money) Jun 2020 | 24 | 2005 | — |
| 9 |
BDI biotech
R&D center engaged in the development of microbial strains |
$4.8M | — | Seed | Grant (prize money) Jan 2021 | 50 | 2014 | — |
| 10 |
Biobide
CRO specializing in Zebrafish toxicity and efficacy assays |
$431.5K | — | Funding Raised | Grant (prize money) Sep 2023 | 17 | 2005 | — |
| 11 |
Vivia Biotech
Developer of precision medicine test for hematologic cancers |
$7.5M | — | Series A | Conventional Debt Apr 2012 | — | 2007 | — |
| 12 |
Zebrafish Lab
Zebrafish based services for preclinical and environmental applications |
$2.3M | — | Funding Raised | Grant (prize money) Aug 2019 | — | 2015 | — |
| 13 |
AtG
CRO focused on providing drug discovery and development services to metabolic disease |
$567.8K | — | Seed | Seed Jul 2022 | 5 | 2021 | — |
| 14 |
Beyond You
Provider of transcriptomic tests that focused on reversing aging |
$81.9K | — | Funding Raised | Grant (prize money) Jul 2023 | 16 | 2020 | — |
| 15 |
Celtarys
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery |
$81.9K | — | Funding Raised | Grant (prize money) Jul 2023 | 8 | 2021 | — |
| 16 |
MolDrug AI Systems
Provider of computational chemistry and molecular modeling services for drug discovery |
$390.3K | — | Funding Raised | Grant (prize money) Jun 2021 | — | 2018 | — |
| 17 |
MedBioInformatics Solutions
Provider of NLP and AI solutions for life science data analysis. |
$428.6K | — | Funding Raised | Grant (prize money) Jun 2021 | 9 | 2010 | — |
| 18 |
i+Med
Biomedical engineering company specializing in the research, development, and manufacturing of biomedical devices and innovative medicines |
$402.1K | — | Funding Raised | Grant (prize money) Jan 2020 | 67 | 2013 | — |
| 19 |
Specipig
CRO Specializing in Swine Models |
$605.1K | — | Seed | Seed Mar 2016 | 18 | 2013 | — |
| 20 |
IDIVAL
Provider of research, clinical trial, and training services |
$286.7K | — | Funding Raised | Grant (prize money) Jan 2021 | — | 2012 | — |
| 21 |
Bioithas
Research center specializing in the management of licenses, patents, and other sanitary registries for direct exploitation |
$111K | — | Funding Raised | Grant (prize money) Nov 2019 | — | 2017 | — |
| 22 |
Enzymlogic
CRO working on enzymology and binding kinetics analysis for small-molecule drug discovery programs for Biopharma companies |
$111K | — | Seed | Grant (prize money) Nov 2019 | 10 | 2013 | — |
| 23 |
Nostrum Biodiscovery
Manufacturer of drug discovery and development services |
$141.4K | — | Funding Raised | Grant (prize money) Jan 2019 | — | 2016 | — |
| 24 |
StemTek Therapeutics
Stem cell focused research services for drug development for cancer treatment |
$107.8K | — | Deadpooled | Grant (prize money) Apr 2017 | — | 2013 | — |
| 25 |
BioDatup
Provider of a platform for clinical trial data management and analysis |
$58.3K | — | Funding Raised | Grant (prize money) Aug 2018 | — | 2017 | — |
| 26 |
IMG Pharma Biotech
Provider of analytical services and customized tools for biomolecule characterization |
$57.5K | — | Funding Raised | Grant (prize money) Apr 2017 | — | 2010 | — |
| 27 |
Curapath
Developer of drug delivery systems for therapeutic purposes |
$14.1K | — | Acquired | Grant (prize money) Jan 2020 | 43 | 2013 | — |
| 28 |
Insud Pharma
Developer and manufacturer of finished formulations, APIs and monoclonal antibodies |
— | — | Funding Raised | Grant (prize money) Nov 2024 | — | 1977 | ↑ Active |
| 29 |
GalChimia
Drug discovery and development services for small molecules |
— | — | Funding Raised | Grant (prize money) Feb 2024 | 40 | 2001 | — |
| 30 |
Asphalion
Scientific and regulatory support services for drug development |
— | — | Funding Raised | Dec 2021 | — | 2000 | — |
| 31 |
Galenicum
Turnkey solutions for drug development, manufacturing and regulatory approvals |
— | — | Late Stage | PE Sep 2021 | 473 | 2003 | — |
| 32 |
HTBA
CDMO focused on manufacturing pharmaceutical API |
— | — | Funding Raised | Unattributed Dec 2019 | 140 | 2019 | — |
| 33 |
Ocupharm Diagnostics
Provider of pharmaceutical research services for drug and medical device research and development process |
— | — | Funding Raised | Sep 2019 | — | 2006 | — |
| 34 |
Anaxomics
Provider of Systems Biology solutions to industry and academia |
— | — | Funding Raised | Jan 2019 | — | 2005 | — |
| 35 |
Vivotecnia
Preclinical contract research services for biopharma companies |
— | — | Acquired | Grant (prize money) Oct 2017 | 177 | 2002 | — |
| 36 |
Idifarma
Services for developing and manufacturing drugs in a wide range of dosage forms |
— | — | Acquired | Series B Sep 2016 | 120 | 2001 | — |
| 37 |
Alpha Bioresearch
Full-service CRO based out of Spain |
— | — | Deadpooled | May 2015 | — | 2006 | — |
| 38 |
Gadea
CDMO offering its services for APIs and FDFs |
— | — | Acquired | Oct 2008 | — | 1991 | — |
| 39 |
3P Biopharmaceuticals
CDMO specializing in biologics, biosimilars and cell therapy products |
— | — | Acquired | — | 350 | 2006 | — |
| 40 |
3PBiovian
CDMO focused on developing viral vectors |
— | — | Funding Raised | — | — | 2024 | — |
| 41 |
ABABOR Pharmaceuticals
Manufacturer of tablets and capsules |
— | — | Unfunded | — | — | 2014 | — |
| 42 | Actiomed Farmacovigilancia | — | — | Acquired | — | 30 | 2001 | — |
| 43 |
Adamed Laboratories
Manufacturer of tablets, capsules, syrup, and injectables |
— | — | Unfunded | — | — | 2009 | — |
| 44 |
ADL Biopharma
Developer and manufacturer of APIs and intermediates |
— | — | Acquired | — | 300 | 2014 | — |
| 45 |
Agrinco Organics
Provider of research & development services for medicinal cannabis products |
— | — | Deadpooled | — | — | 2020 | — |
| 46 |
Alcal Farma
CDMO for OTC products and food supplements. |
— | — | Acquired | — | 239 | 1995 | — |
| 47 |
AMS Biopharma
A biopharma company offering analytical services for drug development |
— | — | Unfunded | — | — | 2018 | — |
| 48 |
anapharm bioanalytics
Anapharm Bioanalytics is a bioanalytical contract research organization that offers clinical and statistical services for clinical trials. |
— | — | Acquired | — | 69 | 2003 | — |
| 49 |
Anapharm Bioanalytics
CRO offering bioanalytical and assay development services |
— | — | Unfunded | — | — | 2003 | — |
| 50 |
AP21 Pharm
Provider of consulting, technical auditing, and business development for regulated industries |
— | — | Unfunded | — | — | 2019 | — |
CDMO company manufacturing APIs and intermediates. It supports customers through its new chemical entity programs from pre-clinical stages to commercial production. It also offers comprehensive chemical manufacturing capabilities such as hydrogenation, chlorination, and micronization.
Provider of preclinical services for the development of oncology drugs
Developer of genomic treatments and technologies intended for neurological diseases. The company develops innovative gene therapy for the treatment of Friedreich's ataxia, a rare neurological disease, enabling patients with Friedreich's ataxia, a rare neurodegenerative disease for which there is currently no treatment.
Manufacturer of biopharmaceutical product in immunotherapy. The company has developed recombinant protein in E. coli, CHO mammalian cell line, P. pastoris and S. cerevisiae. The company has developed a platform for upstream (USP) and downstream (DSP) of microbial and mammalian cell cultures and purification of a biotherapeutics. It also developed a platform for the analysis and formulation of protein therapeutics.
Provider of CRO developing zebrafish models for toxicity studies. The company is supported by University Pompeu Fabra (UPF) and incubated at Barcelona Biomedicine Research Park (PRBB). Services offered by the company include toxicity, efficacy, and genesis assay on zebrafish (using CRISPR/Cas9 technology). Their proprietary models have been licensed by Harvard, MIT, and Broad Institute.
Provider of particle design, nanoformulation technologies, and cGMP particle characterization services. It delivers advanced solutions and technologies to obtain high-added value products through particle design and nanoformulation. It is active in collaborative projects, applying micro and nanotechnology to biomedical and healthcare purposes. The company offers contract analysis on particle characterization, providi
Developer of a digital platform designed to accelerate the results of clinical trials for the benefit of patients. The company's services collect data from all stages and agents involved in the clinical trial process, and they provide value-added services supported by data-driven SaaS technology and application to improve clinical testing stages under strict scientific rigor and in compliance with regulatory framewor
HistoCell is a spin-off from the University of the Basque Country and engages in developing new technologies in regenerative medicine. The company uses Adult Mesenchymal Stem Cells (AMSCs) and bioactive materials (scaffolds) as their key technology and focuses n these therapeutic areas bone regeneration, advanced wound healing, inflammatory diseases, neurodegeneration, and ischemia or lung therapy. The product line o
BDI Biotech is a biotechnology company offering biopharma drug development services through its expertise in product expression under different platforms (yeast, bacteria, and fungi), upstream and downstream process development, scale-up and contract manufacturing. The company has two main divisions namely BDI Health and BDI Food. The company has developed a patented and proprietary antigen-display nanoplatforms base
Biobide is a CRO, offering standard assays and custom-made solutions for Zebrafish based toxicity and efficacy testing services (GLP compliant) to the pharmaceutical, biotech, chemical, cosmetic and nutraceutical companies. Biobide's Zebrafish service portfolio includes target validation, disease model generation, toxicity assays such as multitox, acutetox, teratotox, cardiotox, hepatotox, ototox, ecotox and behavior
Developer of precision medicine test for hematologic cancers. It is focused on analyzing the effect of existing drugs directly on a patient’s standard biological sample such as blood or bone marrow using its proprietary ExviTech technological platform. It has also developed medicine test for the treatment of hematological malignancies like leukemia and multiple myeloma. The company partners with pharmaceutical & bi
The Zebrafish Lab is a preclinical CRO developing and commercializing in vivo zebrafish assays for evaluating adverse side effects of new drug compounds. Apart from the pharma and the biotech industries, their services also cater to the environment, natural product, nutraceutical, agrochemical, food, cosmeceutical and skin care industries. Their offering includes a wide range of Zebrafish models namely, Zebratoxifish
Europa
EIC Fund
Sodena
Caixa Capital Risc
Clave
Inveready
Keensight Capital
MCH
Suanfarma
AVANTECA
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-20.
